$9.51
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. The company is headquartered in Carlsbad, California and currently employs 913 full-time employees. The company went IPO on 2006-06-02. and SafeOp Surgical, Inc., is a medical device company. The company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. Its Organic Innovation Machine is focused on developing new approaches that integrate with its expanding InformatiX Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include InformatiX, positioners, access systems, implants and fixation systems, and biologics. Its InformatiX product platform comprises EOS imaging system, EOS Insight alignment assessment and surgical planning web/mobile platform, SafeOp Neural InformatiX System and navigation-enabled robotics platform. The company has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
Country

US

CEO

Mr. Patrick Miles

IPO date

2006

Employees

913

ISIN

US02081G2012

Key stats

Open

$9.35

Volume

1.74M

Market cap

$1.42B

Prev. close

$9.51

Impl / hst vl

-

Open interest

$0.00

$9.18

Day’s Range

$9.52

$6.82

52W Range

$23.29

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
1.74
P/B
75.20
Current ratio
1.90
Debt / Equity
23.75
ROE
-366.63%
Gross margin
71.04%
Income growth
56.04%
FCF growth
-327.79

Analysts estimates

Consensus rating
Buy

The average rating from top 12 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$17.71
The top 14 analysts forecasts that 12-month price may increase by 86.23%, with a low of $11.11 and a high of $25.20
$11.11
Low
$17.71
Avg
$25.20
High
Current price

Earnings

Q1 ‘26 revenue
$192.11M
Q1 ‘26 net income
-$33.91M
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.07
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply